You're reading the free version. Trader adds the live tape and alerts.
Start tracking
BLTE Sale Disclosure
Scholl Hendrik Peter · SEC Form 4 · Filed Jun 17, 2026
Sale
Calculated transaction value
$282.64K
Scholl Hendrik Peter Chief Medical Officer
BLTE
Belite Bio, Inc
BLTE
Transaction date
Jun 16, 2026
Public filing date
Jun 17, 2026
Filing lag
Filed 1 day later
BLTE daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- American depositary share
- Quantity / price
- 2,054 shares @ $137.61
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-273321
Filing cohort
Transactions in this filing
Showing 8 of 8
Trades
8
Issuers
1
Estimated value
$1.41M
Buys / sales
0 / 8
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Belite Bio, Inc BLTE Current | Sale | Jun 16, 2026 | $282.64K |
| Belite Bio, Inc BLTE | Sale | Jun 16, 2026 | $108.33K |
| Belite Bio, Inc BLTE | Sale | Jun 16, 2026 | $438.26K |
| Belite Bio, Inc BLTE | Sale | Jun 16, 2026 | $75.91K |
| Belite Bio, Inc BLTE | Sale | Jun 16, 2026 | $14.18K |
| Belite Bio, Inc BLTE | Sale | Jun 16, 2026 | $63.99K |
| Belite Bio, Inc BLTE | Sale | Jun 16, 2026 | $272.31K |
| Belite Bio, Inc BLTE | Sale | Jun 16, 2026 | $150.1K |